MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

metabolic risk

  • Home
  • metabolic risk
Linking Endometriosis Subtypes to Increased Risk of Type 2 Diabetes: Insights from the ARCHES Study
Posted inDiabetes & Endocrinology news OB/GYN & Women’s Health

Linking Endometriosis Subtypes to Increased Risk of Type 2 Diabetes: Insights from the ARCHES Study

Posted by By MedXY 08/08/2026
The ARCHES retrospective cohort study reveals that endometriosis significantly elevates the risk of type 2 diabetes, particularly in specific subtypes and among premenopausal women with lower BMI, highlighting the importance of subtype-specific metabolic risk assessment.
Read More
Delayed Puberty in Male Adolescents: A Novel Risk Factor for Early-Onset Type 2 Diabetes
Posted inDiabetes & Endocrinology news Pediatrics

Delayed Puberty in Male Adolescents: A Novel Risk Factor for Early-Onset Type 2 Diabetes

Posted by By MedXY 01/30/2026
A nationwide cohort study of nearly 1 million Israeli males demonstrates that delayed puberty is independently associated with an increased risk of type 2 diabetes in early adulthood, suggesting it is a marker for long-term metabolic dysfunction.
Read More
Type 2 Diabetes Quadruples Risk of Hearing Loss — Meta-analysis Finds Predominant High-Frequency Impairment and Links to Duration and HbA1c
Posted inDiabetes & Endocrinology news Otorhinolaryngology

Type 2 Diabetes Quadruples Risk of Hearing Loss — Meta-analysis Finds Predominant High-Frequency Impairment and Links to Duration and HbA1c

Posted by By MedXY 11/04/2025
A PRISMA systematic review and meta-analysis of 17 studies (2019–2024) found type 2 diabetes is associated with a 4.19-fold greater odds of hearing loss, especially at high frequencies; duration >10 years and higher HbA1c amplified risk.
Read More
  • Evaluating the Impact of Palliative Radiotherapy Timing on End-of-Life Care in Gynecologic Malignancies
  • Advancing Sentinel Lymph Node Biopsy in Vulvar Cancer: Real-Time Near-Infrared Fluorescence Imaging Enhances Detection and Safety
  • Disparities in Ovarian Cancer Clinical Trial Access Linked to Social Vulnerability: A U.S. County-Level Analysis
  • Laparoscopic Radiofrequency Ablation versus Myomectomy: Comparative Effects on Uterine Leiomyoma Symptoms and Quality of Life
  • Hip Extension Versus Usual Positioning at Crowning: Impact on Perineal Lacerations in First Vaginal Deliveries
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification semaglutide SGLT2 inhibitors stroke type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top